Associate Professor David Preiss
PhD FRCPath MRCP
- Honorary Consultant in Metabolic Medicine
MRC Population Health Research Unit, Clinical Trial Service Unit and Epidemiological Studies Unit
David Preiss studied medicine at the University of Pretoria, South Africa, and qualified as a consultant in Chemical Pathology and Metabolic Medicine in 2012. He was appointed as a Senior Clinical Research Fellow at CTSU in September 2015. He completed his thesis, examining the links between glycaemia and cardiovascular disease, in 2011/2012 and was awarded the University of Glasgow’s Bellahouston Medal for this research. He was recipient of a Rising Star Fellowship from the European Foundation for the Study of Diabetes in 2013, and was also awarded the Royal College of Pathology’s Research Medal for Clinical Biochemistry in 2010.
His major interest is the prevention of cardiovascular disease with particular focus on lipid modification and diabetes. His current research combines clinical trials, epidemiological studies and meta-analyses of major studies. He is Chief Investigator for the NIHR funded LENS trial, a major streamlined study which is investigating the effect of the cholesterol-lowering drug, fenofibrate, on the progression of diabetic eye disease.